Boqii Holding Ltd annual report, Q4 FY2023

Business context and reporting period

Boqii Holding Limited is a China-focused pet-products and services platform, selling through its own online mall, third-party e-commerce stores and an offline distribution network. The filing is an annual Form 20-F for the fiscal year ended March 31, 2023, not a standalone 2022 Q4 report; quarterly figures are not provided here. Financial statements are prepared under U.S. GAAP. Unless stated otherwise, amounts below are RMB.

Key financial metrics

Metric	FY ended Mar. 31, 2023	FY ended Mar. 31, 2022
Revenue	RMB1,092.1m (US$159.0m)	RMB1,186.4m
Gross profit / margin	RMB233.5m / 21.4%	RMB242.7m / 20.5%
Operating loss	RMB103.8m	RMB138.2m
Net loss	RMB106.0m (US$15.4m)	RMB132.8m
Operating cash flow	Use of RMB54.1m	Use of RMB147.5m
Cash and cash equivalents at year-end	RMB89.9m (US$13.1m)	RMB162.9m
Short-term investments at year-end	RMB69.8m	RMB128.1m
Working capital at year-end	Positive RMB210.0m	Positive RMB262.7m

At March 31, 2023, current liabilities were RMB196.1m. Short-term borrowings were RMB86.3m and non-current other debt was RMB102.8m; the company said all short-term borrowings outstanding at year-end were subsequently repaid. Total liabilities were RMB315.8m and shareholders’ equity RMB217.8m. Lease liabilities are additional. Cash flow from investing was positive RMB46.5m and financing cash flow was negative RMB76.7m.

Material changes versus the prior comparable period

• Revenue fell 7.9%, with product-sales revenue down from RMB1,137.3m to RMB1,048.5m and online marketing and information-services revenue down from RMB49.1m to RMB43.6m. Management attributed the decreases primarily to the impact of COVID-19 in China.
• Gross profit declined 3.8%, but gross margin rose from 20.5% to 21.4%. Management cited improved private-label margins and a higher mix of pet supplies and healthcare products.
• Net loss narrowed 20.2%, and operating cash use improved. Sales and marketing expenses fell 27.5% and general and administrative expenses fell 38.9%, reflecting lower advertising, personnel, share-based compensation and professional costs.
• Goodwill was fully impaired: the company recorded a RMB40.7m charge in FY2023 after concluding the reporting unit’s fair value was below its carrying value. No goodwill remained at year-end.
• GMV declined from RMB2,907.2m to approximately RMB2,564.0m. Private-label GMV rose to RMB442.3m and 17.3% of total GMV, from RMB416.4m and 14.3%.
• Offline distribution revenue increased to RMB190.4m, or 17.4% of revenue, from RMB142.0m, or 12.5%. Sales through third-party e-commerce platforms fell to RMB614.5m from RMB703.8m.

Outlook, commentary, risks and unusual items

• Management provided no numerical revenue or earnings guidance. It said cash, cash equivalents, short-term investments and borrowing capacity should be sufficient for anticipated needs for at least the next 12 months, while noting that financing may be needed if conditions change.
• The business has a history of losses and negative operating cash flow. Management’s strategy includes growing private-label sales, expanding offline distribution and customer engagement, and developing additional monetization channels. These initiatives carry execution and investment risks.
• The Cayman Islands holding company operates in China through subsidiaries and VIE contractual arrangements; VIEs generated 79.9% of FY2023 revenue. The company cautions that the arrangements have not been tested in a PRC court and may not provide control equivalent to direct ownership.
• Management concluded internal control over financial reporting and disclosure controls were not effective as of March 31, 2023, due to previously identified material weaknesses involving qualified accounting personnel and documented closing procedures. The auditor’s financial-statement opinion was unqualified; the auditor did not express an opinion on internal-control effectiveness.
• Regulatory and operating exposures include evolving PRC rules on VIEs, data security and overseas offerings; reliance on third-party e-commerce platforms and suppliers; and potential licensing and property-lease compliance issues. The filing notes certain license updates and renewals were in process and that leased properties had not been registered as required.
• The company reported fines of RMB100,000 in December 2021 relating to illegal information on its app and RMB5,000 in May 2023 for failure to promptly stop commercial messages after unsubscribe requests; it said both matters had been rectified. It reported no material pending legal proceedings.
• The NYSE had notified the company of market-capitalization and shareholders’ equity noncompliance and was reviewing a compliance plan. A separate minimum-share-price deficiency was reported as resolved after an ADS ratio change. The company also disclosed that its FY2023 PFIC status was uncertain.
• Other notable exposures include dependence on one supplier, Royal Canin China, which represented 22% of purchases in FY2023, and bank-deposit concentration: approximately 13% of total assets was held at one bank as of year-end. The company said it had not experienced difficulty withdrawing those funds.

Most important facts an investor should verify

• Review the audited statements and cash-flow detail, particularly the decline in cash and investments, continued operating cash burn, and timing of repayment of year-end short-term borrowing.
• Assess whether revenue and GMV weakness has continued after FY2023, and whether higher gross margin and growing private-label and offline sales can offset lower overall sales.
• Track progress on remediation of material weaknesses and any subsequent changes in disclosure controls or financial reporting reliability.
• Evaluate the enforceability and regulatory status of the VIE arrangements, relevant operating licenses, and any CSRC filing requirements for future overseas offerings.
• Check NYSE listing compliance and current trading status, as well as the company’s latest PFIC determination and implications for U.S. investors.